Need professional-grade analysis? Visit stockanalysis.com
$227.01M
N/A
9
N/A
Purple Biotech Ltd (KTOV) trades on TA in ILS. The company is classified in the Healthcare sector under the Biotechnology & Medical Research industry. The stock currently trades at ILS1.00.
Over the past year, KTOV has traded between a low of ILS1.00 and a high of ILS5.00. The stock has lost 80.0% over this period. It is currently 80.0% below its 52-week high.
Purple Biotech Ltd has a market capitalization of $227.01M.
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel.
Side-by-side comparison against top Healthcare peers.